Overall rank by patents
#3,386
Across all tracked assignees
USPTO PatentsView assignee record - 110 granted patents across 33 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
The verdict
West holds 110 US patents across 33 technology areas, rank #3,386 of 50,000 tracked assignees.
West Pharmaceutical Services, Inc. has been granted 110 US utility patents between 2015 and 2025, placing West Pharmaceutical Services, Inc. at rank #3,386 across all assignees tracked by PlainPatent. This portfolio spans 33 distinct Cooperative Patent Classification (CPC) subclasses, averaging 10.4 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a US Corporation, West Pharmaceutical Services, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, West sits between Shanghai Micro Electronics Equipment (group) Co., Ltd (110 patents, rank #3,382) and Bitzer Kühlmaschinenbau Gmbh (109 patents, rank #3,390) - the closest US assignees by grant volume. The composite Innovation Score of 47.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 55 grants, compared with 55 in the 2015–2019 window, a +0% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. West Pharmaceutical Services, Inc.'s 10.4 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 33 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark West Pharmaceutical Services, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
SHANGHAI MICRO ELECTRONICS EQUIPMENT (GROUP) CO., LTD
110 patents
SORRENTO THERAPEUTICS, INC.
110 patents
The ADT Security Corporation
110 patents
The Western Union Company
110 patents
West Pharmaceutical Services, Inc.
110 patents
8 Rivers Capital, LLC
109 patents
Arcam AB
109 patents
Aspire North America LLC
109 patents
BITZER Kühlmaschinenbau GmbH
109 patents
What this shows West holds 110 patents at rank #3,386, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #3,386 in granted patent volume.
Other assignees with the most granted patents in West's primary technology class.
West's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
48 Top 18% higher than 82% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 4 | 3.6% |
| 2016 | 7 | 6.4% |
| 2017 | 14 | 12.7% |
| 2018 | 10 | 9.1% |
| 2019 | 20 | 18.2% |
| 2020 | 9 | 8.2% |
| 2021 | 13 | 11.8% |
| 2022 | 10 | 9.1% |
| 2023 | 11 | 10.0% |
| 2024 | 9 | 8.2% |
| 2025 | 3 | 2.7% |
Top 15 of 33 technology areas
Overall rank by patents
#3,386
Across all tracked assignees
47.6 out of 100
How to use this portfolio
West's 110 grants land it in the top 18% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.